Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

39,124 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30-year results of the Da Qing Diabetes Prevention Outcome Study.
Gong Q, Zhang P, Wang J, Ma J, An Y, Chen Y, Zhang B, Feng X, Li H, Chen X, Cheng YJ, Gregg EW, Hu Y, Bennett PH, Li G; Da Qing Diabetes Prevention Study Group. Gong Q, et al. Among authors: zhang b, zhang p. Lancet Diabetes Endocrinol. 2019 Jun;7(6):452-461. doi: 10.1016/S2213-8587(19)30093-2. Epub 2019 Apr 26. Lancet Diabetes Endocrinol. 2019. PMID: 31036503 Free PMC article.
Higher blood pressure predicts diabetes and enhances long-term risk of cardiovascular disease events in individuals with impaired glucose tolerance: Twenty-three-year follow-up of the Daqing diabetes prevention study.
Li X, Wang J, Shen X, An Y, Gong Q, Li H, Zhang B, Shuai Y, Chen Y, Hu Y, Li G. Li X, et al. Among authors: zhang b. J Diabetes. 2019 Jul;11(7):593-598. doi: 10.1111/1753-0407.12887. Epub 2019 Feb 3. J Diabetes. 2019. PMID: 30556339 Free PMC article. Clinical Trial.
Associations of progression to diabetes and regression to normal glucose tolerance with development of cardiovascular and microvascular disease among people with impaired glucose tolerance: a secondary analysis of the 30 year Da Qing Diabetes Prevention Outcome Study.
Chen Y, Zhang P, Wang J, Gong Q, An Y, Qian X, Zhang B, Li H, Gregg EW, Bennett PH, Li G. Chen Y, et al. Among authors: zhang b, zhang p. Diabetologia. 2021 Jun;64(6):1279-1287. doi: 10.1007/s00125-021-05401-x. Epub 2021 Feb 19. Diabetologia. 2021. PMID: 33608769
Long-term influence of type 2 diabetes and metabolic syndrome on all-cause and cardiovascular death, and microvascular and macrovascular complications in Chinese adults - A 30-year follow-up of the Da Qing diabetes study.
He S, Wang J, Zhang X, Qian X, Yan S, Wang W, Zhang B, Chen X, An Y, Gong Q, Zhang L, Zhu X, Li H, Chen Y, Li G. He S, et al. Among authors: zhang l, zhang b, zhang x. Diabetes Res Clin Pract. 2022 Sep;191:110048. doi: 10.1016/j.diabres.2022.110048. Epub 2022 Aug 24. Diabetes Res Clin Pract. 2022. PMID: 36029887 Free article.
The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study.
Li G, Zhang P, Wang J, Gregg EW, Yang W, Gong Q, Li H, Li H, Jiang Y, An Y, Shuai Y, Zhang B, Zhang J, Thompson TJ, Gerzoff RB, Roglic G, Hu Y, Bennett PH. Li G, et al. Among authors: zhang b, zhang p, zhang j. Lancet. 2008 May 24;371(9626):1783-9. doi: 10.1016/S0140-6736(08)60766-7. Lancet. 2008. PMID: 18502303
39,124 results
You have reached the last available page of results. Please see the User Guide for more information.